Your browser doesn't support javascript.
loading
CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214.
Benoit, Bernice M; Jariwala, Neha; O'Connor, Geraldine; Oetjen, Landon K; Whelan, Timothy M; Werth, Adrienne; Troxel, Andrea B; Sicard, Hélène; Zhu, Lisa; Miller, Christopher; Takeshita, Junko; McVicar, Daniel W; Kim, Brian S; Rook, Alain H; Wysocka, Maria.
Afiliación
  • Benoit BM; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Blvd, 1049 BRB, Philadelphia, PA, 19104, USA.
  • Jariwala N; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Blvd, 1049 BRB, Philadelphia, PA, 19104, USA.
  • O'Connor G; National Cancer Institute, Cancer and Inflammation Program, Frederick, MD, USA.
  • Oetjen LK; Division of Dermatology, Department of Medicine, Washington University, St. Louis, MO, USA.
  • Whelan TM; The Division of Biology and Biomedical Sciences, Washington University, St. Louis, MO, USA.
  • Werth A; Division of Dermatology, Department of Medicine, Washington University, St. Louis, MO, USA.
  • Troxel AB; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Blvd, 1049 BRB, Philadelphia, PA, 19104, USA.
  • Sicard H; Department of Biostatistics and Epidemiology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Zhu L; Innate Pharma, Research and Drug Development, Marseille, France.
  • Miller C; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Blvd, 1049 BRB, Philadelphia, PA, 19104, USA.
  • Takeshita J; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Blvd, 1049 BRB, Philadelphia, PA, 19104, USA.
  • McVicar DW; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, 421 Curie Blvd, 1049 BRB, Philadelphia, PA, 19104, USA.
  • Kim BS; National Cancer Institute, Cancer and Inflammation Program, Frederick, MD, USA.
  • Rook AH; Division of Dermatology, Department of Medicine, Washington University, St. Louis, MO, USA.
  • Wysocka M; Department of Anesthesiology, Washington University, St. Louis, MO, USA.
Arch Dermatol Res ; 309(1): 11-19, 2017 Jan.
Article en En | MEDLINE | ID: mdl-27766406
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Proteínas del Grupo de Alta Movilidad / Receptores Inmunológicos / Linfocitos T CD4-Positivos / Biomarcadores de Tumor / Linfocitos Infiltrantes de Tumor / Síndrome de Sézary / MicroARNs Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Arch Dermatol Res Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Proteínas del Grupo de Alta Movilidad / Receptores Inmunológicos / Linfocitos T CD4-Positivos / Biomarcadores de Tumor / Linfocitos Infiltrantes de Tumor / Síndrome de Sézary / MicroARNs Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Límite: Humans Idioma: En Revista: Arch Dermatol Res Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos